======= ANAPC1 ======= == Gene Information == * **Official Symbol**: ANAPC1 * **Official Name**: anaphase promoting complex subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=64682|64682]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9H1A4|Q9H1A4]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANAPC1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANAPC1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608473|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. {ECO:0000269|PubMed:18485873}. |Apc1| |metaphase/anaphase transition of cell cycle| |metaphase/anaphase transition of mitotic cell cycle| |anaphase-promoting complex| |protein K11-linked ubiquitination| |regulation of mitotic sister chromatid separation| |regulation of chromosome separation| |regulation of mitotic sister chromatid segregation| |regulation of sister chromatid segregation| |anaphase-promoting complex-dependent catabolic process| |regulation of chromosome segregation| |regulation of mitotic nuclear division| |regulation of nuclear division| |ubiquitin protein ligase activity| |mitotic cell cycle phase transition| |cell cycle phase transition| |protein polyubiquitination| |proteasome-mediated ubiquitin-dependent protein catabolic process| |regulation of chromosome organization| |proteasomal protein catabolic process| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |cell division| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |mitotic cell cycle process| |cellular protein catabolic process| |regulation of mitotic cell cycle| |protein catabolic process| |mitotic cell cycle| |protein ubiquitination| |regulation of cell cycle process| |protein modification by small protein conjugation| |cellular macromolecule catabolic process| |protein modification by small protein conjugation or removal| |cell cycle process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |regulation of cell cycle| |proteolysis| |regulation of organelle organization| |cell cycle| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-1.92| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-1.86| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-1.75| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.409| Global Fraction of Cell Lines Where Essential: 394/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|16/28| |blood|13/28| |bone|15/26| |breast|21/33| |central nervous system|37/56| |cervix|3/4| |colorectal|8/17| |esophagus|7/13| |fibroblast|1/1| |gastric|7/16| |kidney|12/21| |liver|12/20| |lung|39/75| |lymphocyte|4/16| |ovary|14/26| |pancreas|6/24| |peripheral nervous system|6/16| |plasma cell|6/15| |prostate|1/1| |skin|10/24| |soft tissue|6/9| |thyroid|2/2| |upper aerodigestive|9/22| |urinary tract|14/29| |uterus|4/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2577 * **Expression level (log2 read counts)**: 7.96 {{:chemogenomics:nalm6 dist.png?nolink |}}